Intramuscular dendritic fibromyxolipoma in a 24-year-old male: A case report and review of the literature
- Authors:
- Xia Xu
- Wen Xiong
- Liduan Zheng
- Jie Yu
View Affiliations
Affiliations: Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China, Department of Orthopaedics, Wuhan Puai's Hospital, Wuhan, Hubei 430032, P.R. China, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
- Published online on: December 12, 2014 https://doi.org/10.3892/ol.2014.2794
-
Pages:
583-586
-
Copyright: © Xu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Dendritic fibromyxolipoma (DFML) is an uncommon, benign soft tumor that usually arises in the subcutis. To date, ~24 cases of DFML have been reported in the literature and only one of these has been in the muscle. The present study reports the case of a 24‑year‑old male with a slow‑growing, painless mass located deep in the triceps brachii in the left shoulder region. The mass was 14.0x8.5x8.0 cm in size, with well‑circumscribed margins. Microscopically, the resected mass was characterized by a proliferation of small spindle or stellate cells, prominent abundant myxoid stroma with ropey collagen bundles and admixed mature adipose tissue. Further immunohistochemical staining indicated that the spindle and stellate cells were reactive with cluster of differentiation 34, vimentin and B‑cell lymphoma‑2, but not with smooth muscle actin and desmin. Fluorescence in situ hybridization showed that the tumor cells did not have the DDIT3 alteration or amplification of MDM2. The tumor was confirmed to be a DFML due to the typical histological, immunophenotypic and genetic findings. To date, subsequent to 4 years of clinical follow‑up, there is no sign of recurrence or metastasis. The present study reports a case of DFML in the youngest known patient, and is the second reported case of an intramuscular DFML occurring in the triceps brachii in the left shoulder region. The study discusses the clinicopathological features and the differential diagnosis of DFML, with a review of the literature.
View References
1
|
Suster S, Fisher C and Moran CA: Dendritic
fibromyxolipoma: clinicopathologic study of a distinctive benign
soft tissue lesion that may be mistaken for a sarcoma. Ann Diagn
Pathol. 2:111–120. 1998. View Article : Google Scholar : PubMed/NCBI
|
2
|
Karim RZ, McCarthy SW, Palmer AA, Bonar SF
and Scolyer RA: Intramuscular dendritic fibromyxolipoma: myxoid
variant of spindle cell lipoma? Pathol Int. 53:252–258. 2003.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Tan GM and Wen P: Clinicopathologic
features of dendritic fibromyxolipoma. Zhonghua Bing Li Xue Za Zhi.
32:404–408. 2003.(In Chinese). PubMed/NCBI
|
4
|
Al-Maskery AY, Al-Sidairy SM and
Al-Hamadani AS: Dendritic myxofibrolipoma: often misdiagnosed as
sarcoma. Craniomaxillofac Trauma Reconstr. 4:171–174. 2011.
View Article : Google Scholar :
|
5
|
Dahlin LB and Ljungberg O: Dendritic
fibromyxolipoma adherent to the median nerve in the forearm. J
Plast Surg Hand Surg. 46:120–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang XJ, Zhou S, Nie K, et al: Dendritic
fibromyxolipoma in the right inguinal and perineum regions: a case
report and review of the literature. Diagn Pathol. 8:1572013.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Suster S, Fisher C and Moran CA:
Expression of bcl-2 oncoprotein in benign and malignant spindle
cell tumors of soft tissue, skin, serosal surfaces, and
gastrointestinal tract. Am J Surg Pathol. 22:863–872. 1998.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Guillou L and Coindre JM: Newly described
adipocytic lesions. Semin Diagn Pathol. 18:238–249. 2001.
|
9
|
Templeton SF and Solomon AR Jr: Spindle
cell lipoma is strongly CD34 positive. An immunohistochemical
study. J Cutan Pathol. 23:546–550. 1996. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mandal RV, Duncan LM, Austen WG Jr and
Nielsen GP: Infiltrating intramuscular spindle cell lipoma of the
face. J Cutan Pathol. 36(Suppl 1): 70–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Horiuchi K, Yabe H, Nishimoto K, Nakamura
N and Toyama Y: Intramuscular spindle cell lipoma: Case report and
review of the literature. Pathol Int. 51:301–304. 2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Usta U, Türkmen E, Mizrak B, Yildiz D and
Güzel Z: Spindle cell lipoma in an intramuscular lipoma. Pathol
Int. 54:734–739. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Fletcher CD, Akerman M, Dal Cin P, et al:
Correlation between clinicopathological features and karyotype in
lipomatous tumors. A report of 178 cases from the Chromosomes and
Morphology (CHAMP) Collaborative Study Group. Am J Pathol.
148:623–630. 1996.PubMed/NCBI
|
14
|
Meis-Kindblom JM, Sjögren H, Kindblom LG,
et al: Cytogenetic and molecular genetic analyses of liposarcoma
and its soft tissue simulators: recognition of new variants and
differential diagnosis. Virchows Arch. 439:141–151. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang H, Erickson-Johnson M, Wang X, et
al: Molecular testing for lipomatous tumors: critical analysis and
test recommendations based on the analysis of 405 extremity-based
tumors. Am J Surg Pathol. 34:1304–1311. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Orvieto E, Furlanetto A, Laurino L and Dei
Tos AP: Myxoid and round cell liposarcoma: a spectrum of myxoid
adipocytic neoplasia. Semin Diagn Pathol. 18:267–273. 2001.
|